Follow the 큐렉소 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 큐렉소 has logged 32 public disclosures. Market capitalisation: €306.6bn. The latest transaction was reported on 9 March 2026 (Purchase). Among the most active insiders: 에치와이. The full history is free.
32
Insider Decl.
n/a
Thresholds
€136,534
29 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Buys €136,534n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,788 of 27,940 companies
40.5
score / 100
Value
21
Quality
60
FCF yld-4.5%
Earn yld0.9%
EV/EBITDA54.0x
ROE·
Gross mgn33%
Net mgn3.7%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
큐렉소 is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative medical technologies.